29 studies found for:    RHEUMATOID ARTHRITIS, SYSTEMIC JUVENILE
Show Display Options
Rank Status Study
1 Completed Ultrasonography in Juvenile Idiopathic Arthritis
Conditions: Juvenile Idiopathic Arthritis, Oligoarthritis;   Polyarticular Juvenile Rheumatoid Arthritis;   Systemic Juvenile Idiopathic Arthritis
Intervention: Device: Ultrasonography
2 Recruiting A Study of RoActemra/Actemra (Tocilizumab) in Patients Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis, Rheumatoid Arthritis
Intervention: Drug: Tocilizumab [RoActemra/Actemra]
3 Active, not recruiting Safety and Effectiveness of Rilonacept for Treating Systemic Juvenile Idiopathic Arthritis in Children and Young Adults
Condition: Juvenile Idiopathic Arthritis
Intervention: Biological: Rilonacept
4 Unknown  Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases
Conditions: Purpura, Schoenlein-Henoch;   Graft Versus Host Disease;   Anemia, Hemolytic, Autoimmune;   Rheumatoid Arthritis;   Churg-Strauss Syndrome;   Hypersensitivity Vasculitis;   Wegener's Granulomatosis;   Systemic Lupus Erythematosus;   Giant Cell Arteritis;   Pure Red Cell Aplasia;   Juvenile Rheumatoid Arthritis;   Polyarteritis Nodosa;   Autoimmune Thrombocytopenic Purpura;   Takayasu Arteritis
Interventions: Drug: anti-thymocyte globulin;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: filgrastim;   Drug: methylprednisolone;   Drug: prednisone;   Procedure: Autologous Peripheral Blood Stem Cell Transplantation
5 Unknown  Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases
Conditions: Rheumatoid Arthritis;   Spondyloarthritis;   Systemic Lupus Erythematosus (SLE);   Dermatomyositis (DM);   DMixed Connective Tissue Disease;   Systemic Vasculitis;   Systemic Sclerosis (SSc);   Sjögren's Syndrome;   Antiphospholipid Syndrome;   Juvenile Idiopathic Arthritis;   Juvenile SLE;   Juvenile DM
Intervention: Biological: Anti-pandemic H1N1 influenza vaccine
6 Completed Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders
Conditions: Systemic Sclerosis;   Systemic Lupus Erythematosus;   Dermatomyositis;   Juvenile Rheumatoid Arthritis;   Autoimmune Diseases
Intervention: Procedure: Stem Cell Transplantation
7 Completed Safety, Efficacy and Pharmacokinetics of Subcutaneous ACZ885 in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)
Condition: Arthritis, Juvenile Rheumatoid
Intervention: Drug: ACZ885
8 Terminated Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis
Condition: Juvenile Rheumatoid Arthritis
Interventions: Drug: Enbrel;   Drug: Placebo
9 Completed
Has Results
Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)
Condition: Systemic Juvenile Idiopathic Arthritis With Active Flare
Interventions: Drug: canakinumab;   Drug: placebo
10 Terminated
Has Results
Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA)
Condition: Systemic Juvenile Idiopathic Arthritis
Interventions: Drug: Canakinumab;   Drug: Placebo
11 Recruiting An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.
Condition: Systemic Juvenile Idiopathic Arthritis
Intervention: Drug: Canakinumab
12 Not yet recruiting An Open-label, Multi-arm, Non-comparative Safety and Tolerability Study of Canakinumab (ACZ885) in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)
Condition: Systemic Juvenile Idiopathic Arthritis
Interventions: Drug: Canakinumab - Cohort 1;   Drug: Canakinumab - Cohort 2
13 Completed Study to Evaluate the Safety and Tolerability of Two Doses of Rilonacept in Pediatric Subjects With Active Systemic Juvenile Idiopathic Arthritis (SJIA)
Condition: Systemic Juvenile Idiopathic Arthritis
Interventions: Drug: rilonacept (IL-1 Trap);   Other: Placebo
14 Completed Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)
Condition: Systemic Juvenile Idiopathic Arthritis
Interventions: Drug: MRA(Tocilizumab);   Drug: placebo
15 Completed Long-term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)
Condition: Systemic Juvenile Idiopathic Arthritis
Intervention: Drug: MRA(Tocilizumab)
16 Completed Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)
Condition: Systemic Juvenile Idiopathic Arthritis
Intervention: Drug: MRA(Tocilizumab)
17 Recruiting A Study of Subcutaneously Administered RoActemra/Actemra (Tocilizumab) in Patients With Systemic Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: tocilizumab [RoActemra/Actemra]
18 Recruiting A Study of Decreased Dose Frequency in Patients With Systemic Juvenile Arthritis Who Experience Laboratory Abnormalities During Treatment With RoActemra/Actemra (Tocilizumab)
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: tocilizumab [RoActemra/Actemra]
19 Active, not recruiting
Has Results
A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Systemic Juvenile Idiopathic Arthritis (JIA)
Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra];   Drug: Placebo;   Drug: Non-steroidal anti-inflammatory drugs (NSAIDs);   Drug: methotrexate;   Drug: corticosteroids
20 Recruiting Extension Study Evaluating the Safety and Efficacy of Subcutaneous RoActemra/Actemra Administration in Patients With Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: tocilizumab [RoActemra]

Previous Page Studies Shown (1-20) Next Page (21-29) Show next page of results
Indicates status has not been verified in more than two years